The Alzheimer’s Drug Discovery Foundation’s 2024 Digital Annual Report, ADDF 2024 Annual Report, has received a MarCom Gold Award in the Annual Report / CSR category. The digital report highlights a future shaped by combination therapies and precision medicine for Alzheimer’s disease, organizing ADDF’s work across therapeutics, diagnostics, and prevention so readers can see how individual projects contribute to a broader pipeline. Motion, infographics, and photography work together to explain what is new, why it matters, and how donors and partners can help promising ideas scale from discovery to patients.
About the Alzheimer’s Drug Discovery Foundation
The Alzheimer’s Drug Discovery Foundation (ADDF) partners with a global community of researchers, clinicians, and donors to accelerate the development of drugs and diagnostics for Alzheimer’s disease. Its venture philanthropy model supports high-potential science that might otherwise struggle to attract funding, with an emphasis on getting effective tools into clinics and communities as quickly as possible.
